• No results found

ArandomizedphaseIIpresurgicaltrialofweeklylow-dosetamoxifenversusraloxifeneversusplaceboinpremenopausalwomenwithestrogenreceptor-positivebreastcancer RESEARCHARTICLEOpenAccess

N/A
N/A
Protected

Academic year: 2022

Share "ArandomizedphaseIIpresurgicaltrialofweeklylow-dosetamoxifenversusraloxifeneversusplaceboinpremenopausalwomenwithestrogenreceptor-positivebreastcancer RESEARCHARTICLEOpenAccess"

Copied!
11
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

A double-blinded, randomized, placebo- controlled trial to evaluate efficacy, safety and tolerability of single doses of tirasemtiv in patients with acetylcholine receptor

This retrospective analysis used pooled data from two randomized placebo-controlled trials: the VITACOG trial in the UK (Controlled-Trials.com, ISRCTN94410159) and the HK

Compari- son of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the ATOZ Weight Loss Study: a

TRIGEN INTERTAN intramedullary nail versus sliding hip screw: a prospective, randomized multicenter study on pain, function, and complications in 684 patients with an

Continuous invasive blood pressure and cardiac output monitoring during cesarean delivery: a randomized, double-blind comparison of low-dose versus high-dose spinal

When comparing premenopausal women with high (≥ 28.5%) versus low (< 28.5%) percent mammographic density, we observed 31% higher daily salivary

A hy- brid type 1 design was applied, where the primary out- come constituted the effect of the MyFood randomized controlled trial [7] while performing a process evaluation to

The present randomized placebo-controlled clinical trial will evaluate whether administration of probiotics for the first 4 weeks of life, compared to placebo, can reduce morbidity